130 related articles for article (PubMed ID: 826117)
21. The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis.
Danis VA; Kulesz AJ; Nelson DS; Brooks PM
Clin Exp Immunol; 1990 Mar; 79(3):335-40. PubMed ID: 2107989
[TBL] [Abstract][Full Text] [Related]
22. Alterations in human monocyte structure and function induced by incubation with gold sodium thiomalate.
Lipsky PE; Ugai K; Ziff M
J Rheumatol Suppl; 1979; 5():130-6. PubMed ID: 114643
[TBL] [Abstract][Full Text] [Related]
23. Immuno-inductive and immuno-suppressive influence of human mononuclear phagocytes cultured in vitro.
Unsgaard G
Acta Pathol Microbiol Scand C; 1977 Oct; 85(5):381-8. PubMed ID: 144410
[TBL] [Abstract][Full Text] [Related]
24. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
Petersen J
Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
[TBL] [Abstract][Full Text] [Related]
25. Partial cross-resistance between auranofin and sodium aurothiomalate in cultured human cells.
Rugstad HE; Glennås A
Scand J Rheumatol; 1988; 17(3):175-81. PubMed ID: 3140371
[TBL] [Abstract][Full Text] [Related]
26. Sulphydryl dependence of the inhibition of mitogen-induced human lymphocyte proliferation by sodium aurothiomalate.
McCormack PL; Palmer DG
Biochem Pharmacol; 1980 Dec; 29(24):3333-6. PubMed ID: 6783048
[No Abstract] [Full Text] [Related]
27. Aurothiomalate inhibits COX-2 expression in chondrocytes and in human cartilage possibly through its effects on COX-2 mRNA stability.
Nieminen R; Vuolteenaho K; Riutta A; Kankaanranta H; van der Kraan PM; Moilanen T; Moilanen E
Eur J Pharmacol; 2008 Jun; 587(1-3):309-16. PubMed ID: 18448096
[TBL] [Abstract][Full Text] [Related]
28. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
[TBL] [Abstract][Full Text] [Related]
29. The effect of sodium aurothiomalate on stimulated and non-stimulated migration by human neutrophils: the role of cyclic GMP.
Elferink JG; Daha MR; De Koster BM
Inflammation; 1997 Feb; 21(1):93-103. PubMed ID: 9179625
[TBL] [Abstract][Full Text] [Related]
30. [Effects of gold compounds on lymphocyte transformation and neutrophil chemotaxis--a comparison between sodium aurothiomalate and auranofin].
Negishi M; Sato H; Sekine F; Ohno I; Kobayashi K; Ohseto Y; Hamai T; Takahashi T
Ryumachi; 1983 Jun; 23(3):163-7. PubMed ID: 6414094
[No Abstract] [Full Text] [Related]
31. In vitro monocyte-lymphocyte interaction influenced by d-penicillamine.
De Vries E; Haasnoot CJ; Van der Weij JP; Cats A
Clin Exp Immunol; 1982 Feb; 47(2):474-80. PubMed ID: 7075029
[TBL] [Abstract][Full Text] [Related]
32. Effects of gold sodium thiomalate on interferon stimulation of C2 synthesis and HLA-DR expression by human monocytes.
Sanders KM; Carlson PL; Littman BH
Arthritis Rheum; 1987 Sep; 30(9):1032-9. PubMed ID: 3117066
[TBL] [Abstract][Full Text] [Related]
33. Study of anti-inflammatory action of aurothiomalate, an inhibitor of NF-κB.
Belsky YP; Ivanova AN; Danilets MG; Belska NV; Ligatcheva AA; Uchasova EG; Reikhart DV
Bull Exp Biol Med; 2011 Jun; 151(2):190-3. PubMed ID: 22238747
[TBL] [Abstract][Full Text] [Related]
34. Effects of aurothiomalate treatment on canine osteosarcoma in a murine xenograft model.
Scharf VF; Farese JP; Siemann DW; Abbott JR; Kiupel M; Salute ME; Milner RJ
Anticancer Drugs; 2014 Mar; 25(3):332-9. PubMed ID: 24304691
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic modulation of TNF production by endotoxin stimulated macrophages: in vitro and in vivo effects of auranofin and other chrysotherapeutic compounds.
Evans GF; Zuckerman SH
Agents Actions; 1989 Mar; 26(3-4):329-34. PubMed ID: 2500010
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of in vitro proliferative response of cultured T lymphocytes to interleukin-2 by gold sodium thiomalate.
Wolf RE; Hall VC
Arthritis Rheum; 1988 Feb; 31(2):176-81. PubMed ID: 3126745
[TBL] [Abstract][Full Text] [Related]
37. The influence of diethyl-dithiocarbamate ('Imuthiol') on mononuclear cells in vitro.
Corke CF
Int J Immunopharmacol; 1984; 6(3):245-7. PubMed ID: 6086540
[TBL] [Abstract][Full Text] [Related]
38. Evidence that suramin and aurothiomalate are teratogenic in rat by disturbing yolk sac-mediated embryonic protein nutrition.
Freeman SJ; Lloyd JB
Chem Biol Interact; 1986 May; 58(2):149-60. PubMed ID: 3087638
[TBL] [Abstract][Full Text] [Related]
39. The morphology and atomic composition of aurosomes produced by sodium aurothiomalate in human monocytes.
Ghadially FN; Lipsky PE; Yang-Steppuhn SE; Lalonde JM
Ann Pathol; 1982; 2(2):117-25. PubMed ID: 6809016
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human phospholipase C by aurothiomalate and (triethylphosphine) gold complexes.
Märki F; Stanton JL
Arzneimittelforschung; 1992 Mar; 42(3):328-33. PubMed ID: 1353962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
